Abiopharma

🔍 Huffman Janet (Executive)

Company: ORAGENICS INC (OGEN)

Report Date: 2025-12-11

Detailed Transactions and Holdings:

• Acquired 250,000 shares of Employee Stock Option (right to buy) at $0.93 per share (Derivative)
  Date: 2025-12-11 | Code: A | Expires: 2035-12-11 | equity_swap_involved: 0 | shares_owned_after: 250,000.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1

Footnotes:

• F1: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One third of the options vest on the first anniversary of the grant date and the remainder of the options subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant.